KRM Ayurveda

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE1MTV01019
  • NSEID: KRMAYURVED
  • BSEID:
INR
254.75
-9.6 (-3.63%)
BSENSE

May 06

BSE+NSE Vol: 369000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.69 lacs (9.56%) Volume

Shareholding (Jan 2026)

FII

6.24%

Held by 18 FIIs

DII

5.20%

Held by 4 DIIs

Promoter

67.28%

Why is KRM Ayurveda Ltd falling/rising?

06-May-2026

As of 05-May, KRM Ayurveda Ltd's stock price is rising to 264.35, reflecting an 8.61% increase. This growth is driven by strong performance against the Sensex, reaching a new all-time high, and increased investor interest, indicating a bullish market trend.

As of 05-May, KRM Ayurveda Ltd's stock price is rising, currently at 264.35, which reflects a change of 20.95 or an increase of 8.61%. This upward movement can be attributed to several factors. <BR><BR>Firstly, the stock has significantly outperformed the benchmark Sensex, with a weekly return of +15.26% compared to the Sensex's mere +0.15%. Over the past month, KRM Ayurveda has shown a remarkable increase of +39.87%, while the Sensex has only gained +5.81%. <BR><BR>Additionally, the stock reached a new 52-week and all-time high of Rs.271 today, indicating strong investor confidence. The performance today has also outpaced the sector by 8.84%, further highlighting its strength in the market. <BR><BR>Moreover, KRM Ayurveda is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bullish trend. The rising investor participation is evident, with a delivery volume of 2.95 lacs on 04 May, which has surged by 485.32% against the 5-day average delivery volume, indicating increased interest from investors. <BR><BR>Finally, the stock's liquidity is adequate, allowing for trades of a size of Rs 0.08 crore based on 2% of the 5-day average traded value. All these factors contribute to the rising stock price of KRM Ayurveda Ltd.

View full answer

Which are the latest news on KRM Ayurveda?

06-May-2026
No latest news for KRM Ayurveda found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 558 Cr (Micro Cap)

stock-summary
P/E

27.00

stock-summary
Industry P/E

61

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.41

stock-summary
Return on Equity

17.54%

stock-summary
Price to Book

4.87

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
44.17%
0%
44.17%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

KRM Ayurveda for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
6.09
Debt to EBITDA (avg)
1.66
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.14
Tax Ratio
24.73%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.11%
ROCE (avg)
41.70%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
27
Industry P/E
0
Price to Book Value
4.71
EV to EBIT
16.78
EV to EBITDA
16.15
EV to Capital Employed
7.32
EV to Sales
4.84
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
43.66%
ROE (Latest)
17.54%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
KST
Dow Theory
Bullish
OBV
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jan 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 18 FIIs (6.24%)

Promoter with highest holding

Puneet Dhawan (90.79%)

Highest Public shareholder

Shyam Sunder (0.81%)

Individual Investors Holdings

15.07%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by KRM Ayurveda"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2026 is 10.28% vs 18.41% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Mar 2026 is 46.19% vs 70.29% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "53.33",
          "val2": "48.36",
          "chgp": "10.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.54",
          "val2": "12.84",
          "chgp": "36.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.54",
          "val2": "1.59",
          "chgp": "-3.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "11.90",
          "val2": "8.14",
          "chgp": "46.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.89%",
          "val2": "26.55%",
          "chgp": "6.34%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by KRM Ayurveda"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 32.84% vs 13.98% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 79.48% vs 228.74% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "101.69",
          "val2": "76.55",
          "chgp": "32.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.49",
          "val2": "18.74",
          "chgp": "62.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.25",
          "val2": "2.90",
          "chgp": "12.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "20.12",
          "val2": "11.21",
          "chgp": "79.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.98%",
          "val2": "24.48%",
          "chgp": "5.50%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Sep'25
Change(%)
Net Sales
53.33
48.36
10.28%
Operating Profit (PBDIT) excl Other Income
17.54
12.84
36.60%
Interest
1.54
1.59
-3.14%
Exceptional Items
0.00
0.00
Standalone Net Profit
11.90
8.14
46.19%
Operating Profit Margin (Excl OI)
32.89%
26.55%
6.34%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Mar 2026 is 10.28% vs 18.41% in Sep 2025

Direction Arrows
Standalone Net Profit

Growth in half year ended Mar 2026 is 46.19% vs 70.29% in Sep 2025

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
101.69
76.55
32.84%
Operating Profit (PBDIT) excl Other Income
30.49
18.74
62.70%
Interest
3.25
2.90
12.07%
Exceptional Items
0.00
0.00
Standalone Net Profit
20.12
11.21
79.48%
Operating Profit Margin (Excl OI)
29.98%
24.48%
5.50%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 32.84% vs 13.98% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 79.48% vs 228.74% in Mar 2025

stock-summaryCompany CV
About KRM Ayurveda Ltd stock-summary
stock-summary
KRM Ayurveda Ltd
Micro Cap
Healthcare Services
KRM Ayurveda Limited was incorporated as a Private Limited Company as "KRM Ayurveda Private Limited" on September 03, 2019. Company was converted into a Public Limited Company and the name of Company was changed to "KRM Ayurveda Limited" on December 24, 2024. Company is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through tele medicines consulting and sales.
Company Coordinates stock-summary
Icon
No Company Details Available